open access

Vol 11, No 5 (2015)
Guidelines / Expert consensus
Published online: 2016-02-17
Get Citation

Recommendations on the treatment of basal cell carcinoma and squamous cell carcinoma prepared by the Oncology Department of the Polish Dermatology Society and the Melanoma Academy Department of the Polish Society of Oncological Surgery

Witold Owczarek, Piotr Rutkowski, Monika Słowińska, Wojciech Wysocki, Marta Sołtysiak, Zbigniew I. Nowecki, Aleksandra Lesiak, Krzysztof Herman, Rafał Czajkowski, Lidia Rudnicka, Arkadiusz Jeziorski
Oncol Clin Pract 2015;11(5):246-255.

open access

Vol 11, No 5 (2015)
EXPERTS' OPINION
Published online: 2016-02-17

Abstract

Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most frequent malignant neoplasms among Caucasian patients. Despite the fact that they seldom metastasise and are not directly fatal, they constitute a significant clinical issue. Such cancers infiltrate surrounding tissues and destroy the surrounding structures, e.g. bones and cartilages, as a result of which such structures develop into severe aesthetic defects and significantly deteriorate the life quality of the patients. Among patients from the high-risk group (namely patients under chronic immunosuppression or those genetically predisposed to develop UV-induced skin cancers) skin cancers may be aggressive and fatal. The Oncology Department of the Polish Dermatology Society (Polish: Sekcja Onkologiczna Polskiego Towarzystwa Dermatologicznego — PTD) and the Melanoma Academy Department of the Polish Society of Oncological Surgery (Polish: Sekcja Akademia Czerniaka Polskiego Towarzystwa Chirurgii Onkologicznej — PTChO), based on the current European guidelines, American recommendations of the National Comprehensive Cancer Network (revision 1.2015), and interventional reviews of publications elaborated by the Cochrane Skin Group, attempted to systemise the diagnostic and therapeutic procedures and determine homogenous rules of primary and secondary prevention in patients suspected/diagnosed with a basal cell or squamous cell carcinoma. This paper presents actual recommendations regarding skin cancer diagnosis and treatment, taking all related benefits and challenges into consideration, as well as recommendations for post-treatment patient monitoring.

Abstract

Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most frequent malignant neoplasms among Caucasian patients. Despite the fact that they seldom metastasise and are not directly fatal, they constitute a significant clinical issue. Such cancers infiltrate surrounding tissues and destroy the surrounding structures, e.g. bones and cartilages, as a result of which such structures develop into severe aesthetic defects and significantly deteriorate the life quality of the patients. Among patients from the high-risk group (namely patients under chronic immunosuppression or those genetically predisposed to develop UV-induced skin cancers) skin cancers may be aggressive and fatal. The Oncology Department of the Polish Dermatology Society (Polish: Sekcja Onkologiczna Polskiego Towarzystwa Dermatologicznego — PTD) and the Melanoma Academy Department of the Polish Society of Oncological Surgery (Polish: Sekcja Akademia Czerniaka Polskiego Towarzystwa Chirurgii Onkologicznej — PTChO), based on the current European guidelines, American recommendations of the National Comprehensive Cancer Network (revision 1.2015), and interventional reviews of publications elaborated by the Cochrane Skin Group, attempted to systemise the diagnostic and therapeutic procedures and determine homogenous rules of primary and secondary prevention in patients suspected/diagnosed with a basal cell or squamous cell carcinoma. This paper presents actual recommendations regarding skin cancer diagnosis and treatment, taking all related benefits and challenges into consideration, as well as recommendations for post-treatment patient monitoring.

Get Citation

Keywords

basal cell carcinoma — BCC, squamous cell carcinoma — SCC, diagnosis, treatment

About this article
Title

Recommendations on the treatment of basal cell carcinoma and squamous cell carcinoma prepared by the Oncology Department of the Polish Dermatology Society and the Melanoma Academy Department of the Polish Society of Oncological Surgery

Journal

Oncology in Clinical Practice

Issue

Vol 11, No 5 (2015)

Article type

Guidelines / Expert consensus

Pages

246-255

Published online

2016-02-17

Bibliographic record

Oncol Clin Pract 2015;11(5):246-255.

Keywords

basal cell carcinoma — BCC
squamous cell carcinoma — SCC
diagnosis
treatment

Authors

Witold Owczarek
Piotr Rutkowski
Monika Słowińska
Wojciech Wysocki
Marta Sołtysiak
Zbigniew I. Nowecki
Aleksandra Lesiak
Krzysztof Herman
Rafał Czajkowski
Lidia Rudnicka
Arkadiusz Jeziorski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl